LONDON - A breakthrough cancer treatment plan could be a "cure" for a death sentence form of the disease. An experimental new treatment being pioneered by Dr Paul Mulholland, a brain cancer specialist at University College London, has proved remarkably successful for some patients - and experts say it could be available within five years. Brain
GAINESVILLE, Fla - Glioblastoma is the most common type of brain cancer, affecting about 3 in every 100,000 people globally each year. Recent research shows that glioblastoma incidence is risingTrusted Source due to an aging population and environmental factors such as air pollutionTrusted Source. Glioblastoma is a challenging cancer to treat and has an average five-year survival rate of 6.9%. Now, researchers from
BOSTON - Brain scans of a 72-year-old man diagnosed with a highly aggressive form of cancer known as a glioblastoma have revealed a remarkable regression in his tumor's size within days of receiving an infusion of an innovative new treatment. Though the outcomes of two other participants with similar diagnoses were somewhat less positive, the case's success still
